In 2013, the Supreme Court of India delivered one of the most consequential patent decisions in the country’s history. In Novartis AG v. Union of India, the Court upheld the rejection of a patent application for imatinib mesylate — the cancer drug Gleevec — after sustained opposition proceedings. The Court applied Section 3(d) of the Patents Act, 1970, holding that a new form of a known substance does not qualify for patent protection unless it demonstrates significantly enhanced known efficacy. The decision validated years of pre-grant opposition efforts by generic manufacturers and public health advocates. It also sent a clear message to the global pharmaceutical industry: India’s patent opposition mechanism is a meaningful, consequential legal tool.
Patent opposition is not a procedural formality. It is a substantive legal process under the Patents Act, 1970 that allows any person — or in the case of post-grant challenges, any interested person to challenge the validity of a patent before or after it is granted. For competitors, public health advocates, research institutions, and businesses operating in innovation-intensive sectors, understanding how to navigate this mechanism is a strategic imperative.
This guide covers both tracks of patent opposition in India — pre-grant under Section 25(1) and post-grant under Section 25(2) — the statutory grounds for challenge, the complete step-by-step procedure, current filing fees, landmark case law, and the strategic decisions that separate a well-prepared challenge from one that fails at the evidence stage.
Legal Foundation: Patent opposition in India is governed by Sections 25(1) and 25(2) of the Patents Act, 1970, read with Rules 55 to 62 of the Patents Rules, 2003 (as amended by the Patents (Amendment) Rules, 2024). Opposition proceedings are heard by the Indian Patent Office (IPO) under the Controller General of Patents, Designs and Trade Marks (CGPDTM). Appeals from the Controller’s decision lie before the jurisdictional High Court of Commercial Jurisdiction following the abolition of the IPAB by the Tribunals Reforms Act, 2021.
Pillar 1 — Pre-Grant Opposition Under Section 25(1): The Challenger’s First Window
What is pre-grant patent opposition in India?
Pre-grant opposition under Section 25(1) of the Patents Act, 1970 allows any person — with no requirement of a specific legal interest — to oppose the grant of a patent after the application has been published but before the patent is formally granted. Publication occurs either 18 months from the priority date under mandatory publication (Section 11A) or earlier upon the applicant’s request.
The breadth of “any person” is intentional. Parliament designed pre-grant opposition as a public participation mechanism — a quality checkpoint allowing third parties, including civil society organisations, generic manufacturers, research institutions, and competing businesses, to flag defects in the claims before they crystallise into a granted monopoly. Furthermore, the absence of a “locus” or “interest” requirement makes this the most accessible track for challenger organisations that may not yet be commercially impacted by the patent.
How do you file a pre-grant opposition?
A pre-grant opposition is filed using Form 7 under the Patents Rules, 2003, accompanied by the prescribed fee. The fee for pre-grant opposition is ₹1,500 for individuals and small entities and ₹6,000 for other applicants when filing online through the IP India e-filing portal. Physical filing adds ₹500 per category.
The opposition statement must clearly identify the grounds of opposition, cite the specific claims being challenged, and attach all supporting evidence — including prior art references, expert affidavits, and technical analyses. Vague or unsubstantiated grounds are routinely dismissed at the preliminary hearing stage. The Controller, on receiving a pre-grant opposition, may refer it to an Examiner for analysis and then conduct a hearing before deciding whether to grant or refuse the patent.
What is the timeline for pre-grant opposition?
Pre-grant opposition may be filed at any point after mandatory publication under Section 11A and before the patent is granted. Notably, an opposition can be filed before the examination of the application is complete — though the Controller will not consider it until examination has been requested and the examination report addressed. There is no fixed deadline for pre-grant opposition beyond the grant date itself. However, applicants often move their applications to grant quickly once examination is complete, so monitoring the IP India patent journal publications is essential for timely intervention.
Strategic Tip — Pre-Grant: Pre-grant opposition is the cheaper and procedurally lighter of the two tracks. It has no locus requirement and lower fees than post-grant proceedings. For pharmaceutical sector challenges, pre-grant opposition under Section 25(1) combined with Section 3(d) arguments is the most efficient path to preventing a problematic patent from being granted. A successful pre-grant challenge eliminates the monopoly before it exists — the most commercially valuable outcome.
Key Takeaway: Section 25(1) pre-grant opposition is India’s first line of defence against invalid patents. Any person can file. The cost is low, the timing is flexible, and a successful challenge prevents the monopoly from being created at all.
Pillar 2 — Post-Grant Opposition Under Section 25(2): The Corrective Mechanism
Who can file a post-grant patent opposition in India?
Post-grant opposition under Section 25(2) of the Patents Act, 1970 permits any “interested person” to oppose a granted patent within 12 months of the date of publication of the grant in the Patent Office journal. The term “interested person” is defined under Section 2(1)(t) of the Act as a person engaged in, or in the promotion of, scientific research, or a person having a commercial interest in the manufacture, use, or sale of the goods concerned with the patent.
The Supreme Court interpreted this definition generously in Novartis AG v. Union of India (2013), recognising that generic pharmaceutical manufacturers and public health advocates with a commercial stake in the relevant market have sufficient interest to maintain post-grant opposition. Similarly, the Bombay High Court in Bayer Corporation v. Union of India (2014) — in the context of compulsory licensing proceedings under Section 84 — acknowledged that India’s patent framework is designed to balance innovation incentives with public access considerations, particularly in life-saving product sectors.
How is a post-grant opposition filed and processed?
A post-grant opposition requires Form 7A under the Patents Rules, 2003, filed within 12 months of the grant publication. The fee for Form 7A is ₹3,000 for individuals and small entities and ₹12,000 for other applicants when filing online. The statement of opposition must identify all grounds, specify the claims challenged, and be accompanied by evidence and a statement of case.
On receipt of Form 7A, the Controller forwards a copy to the patentee, who must file a reply statement — together with any supporting evidence — within two months of receiving the notice. After the patentee files their reply, the opponent has a further one month to file evidence in reply. The evidence stage then closes, and no new grounds or fresh prior art can be introduced thereafter. The Controller refers the matter to an Opposition Board — a three-member panel of patent examiners — which examines all submissions and issues a written recommendation to the Controller.
What is the role of the Opposition Board?
The Opposition Board is a quasi-judicial panel established under Rule 56 of the Patents Rules, 2003. It evaluates all documentary evidence, prior art submissions, expert affidavits, and technical reports submitted by both parties and issues a written recommendation. The Board’s recommendation is advisory — the Controller retains final decision-making authority and must conduct an independent hearing before issuing the final order.
In F. Hoffmann-La Roche Ltd v. Cipla Ltd (Delhi High Court, 2009) — a landmark decision involving erlotinib (Tarceva) — the Court recognised that the Opposition Board process serves a valuable gatekeeping function and that its recommendations carry significant evidentiary weight in the Controller’s final determination. The ruling reinforced that post-grant opposition is a serious adjudicatory process that must be taken as seriously as any court proceeding.
Critical Deadline Alert: The 12-month post-grant window under Section 25(2) is absolute. No extension is available. Missing it forecloses post-grant opposition entirely, leaving revocation under Section 64 (available only as a counter-claim in infringement proceedings) as the remaining challenge route — a significantly more expensive and time-consuming path.
Key Takeaway: Section 25(2) post-grant opposition gives interested parties a 12-month corrective window after grant. Calendar the grant publication date the moment you identify a problematic patent — the deadline is jurisdictional and cannot be extended.
The Statutory Grounds for Patent Opposition Under Section 25
Both pre-grant and post-grant opposition may be founded on the grounds enumerated in Section 25(1)(a) to (k) of the Patents Act, 1970. Each ground has distinct evidentiary requirements and strategic implications.
What are the recognised grounds for patent opposition in India?
Wrongful obtainment — Section 25(1)(a): The patent was obtained by wrongfully deriving the invention from the true inventor. This ground requires evidence of prior disclosure or development by a party other than the applicant.
Prior publication — Section 25(1)(b): The invention was published before the priority date — in India or abroad. The prior publication must clearly anticipate the claims, disclosing every essential element of the invention. Scientific journals, conference papers, patent specifications, and technical reports can all constitute prior art if they predate the priority date.
Prior claiming — Section 25(1)(c): The invention was claimed in a prior Indian patent application with an earlier priority date, creating an internal anticipation conflict.
Public knowledge or use — Section 25(1)(d): The invention was publicly known or used in India before the priority date. This ground is particularly relevant for process patents, where prior commercial manufacturing by domestic entities may predate the filing date.
Obviousness and lack of inventive step — Section 25(1)(e): The claimed invention would have been obvious to a person skilled in the art, given the state of knowledge at the priority date. This is frequently the strongest ground against incremental pharmaceutical patents and engineering improvements. Expert evidence is essential to establish what a person skilled in the relevant art would have found obvious at the relevant date.
Non-patentable subject matter — Section 25(1)(f): The invention falls within the exclusions listed under Sections 3 and 4 of the Patents Act, 1970. Section 3(d) — which bars patents on new forms of known substances without significantly enhanced known efficacy — has been the decisive ground in numerous pharmaceutical oppositions. In Novartis AG v. Union of India (SC, 2013), the Court unanimously upheld the rejection of the imatinib mesylate patent on precisely this ground, confirming that incremental improvements to known chemical compounds are non-patentable in India without demonstrated therapeutic advantage.
Insufficient disclosure — Section 25(1)(g): The complete specification does not sufficiently describe the invention and the method by which it is to be performed. Under Section 10(4) of the Patents Act, the specification must be clear, concise, and complete — enabling a person skilled in the art to reproduce the invention without undue experimentation.
Non-disclosure under Section 8 — Section 25(1)(h): The applicant failed to disclose information required under Section 8 of the Patents Act, or provided materially false information to the Patent Office. Section 8 obliges applicants to disclose all corresponding foreign applications, examination reports received from foreign offices, and prior oppositions filed in other jurisdictions. In Chemtura Corporation v. Union of India (Delhi HC, 2009), the Court emphasised that Section 8 compliance is a substantive obligation. This ground requires only documentary proof — the foreign prosecution file history — and no technical expert evidence, making it uniquely efficient when the documentary record is clear.
Traditional knowledge anticipation — Section 25(1)(k): The claimed invention is anticipated by traditional knowledge of any community, anywhere in the world. The Traditional Knowledge Digital Library (TKDL) — a database of traditional Indian formulations compiled by CSIR — has been used to oppose over 50 foreign patent applications attempting to patent traditional Indian remedies as novel inventions.
Ground Selection Principle: The strongest oppositions combine multiple grounds. Lead with the ground best supported by the available evidence; plead secondary grounds as fallbacks. For pharmaceutical patents, Section 3(d) and obviousness dominate. For technology patents, prior art publication and obviousness are primary. For patents with prosecution defects, Section 8 non-disclosure is a clean documentary ground requiring no technical expert. Never plead grounds you cannot substantiate — unfounded grounds weaken the credibility of the grounds you can prove.
Key Takeaway: The statutory grounds under Section 25 are comprehensive — covering novelty, inventive step, patentability, disclosure, and procedural compliance. Opposition success depends not on the number of grounds pleaded but on the quality of evidence marshalled for each. Patent Registration Services — Unimarks Legal Solutions
The Patent Opposition Procedure: Step by Step
Step 1 — Set Up a Patent Monitoring System. Subscribe to the IP India patent journal, published bi-weekly at ipindia.gov.in. Configure keyword and IPC classification alerts for technology areas, applicant entities, and inventor names relevant to your business. For pharmaceutical companies, monitor by therapeutic class and active ingredient name. For technology companies, monitor by IPC code and competitor entity name.
Step 2 — Conduct a Comprehensive Prior Art Search. Before filing, search across multiple databases WIPO PATENTSCOPE, Espacenet (EPO), IP India Patent Search, USPTO, Google Patents, and sector-specific technical literature databases. The prior art found at this stage determines which grounds are sustainable and how strong the evidence is. A poorly supported opposition creates a prosecution record that the patentee can exploit to argue the patent has survived scrutiny.
Step 3 — Identify Grounds and Instruct Technical Experts. Select the most defensible grounds based on your prior art research and fact investigation. For technical grounds novelty, obviousness, and insufficient disclosure identify and instruct a domain expert who can provide an affidavit explaining the state of the art at the priority date and why the claimed invention fails to meet the statutory standard. Expert evidence is not mandatory for pre-grant opposition but is often decisive in post-grant proceedings before the Opposition Board.
Step 4 — File Form 7 or Form 7A with a Complete Evidence Bundle. Prepare and file the appropriate form through the IP India e-filing portal. Include the completed form, prescribed fee, statement of opposition with claim-by-claim analysis, prior art documents with explanatory notes, expert affidavits (notarised), and a complete document index. Incomplete filings and improperly notarised affidavits are among the most common causes of procedural rejection.
Step 5 — Engage in Evidence Exchange (Post-Grant Proceedings). In post-grant proceedings, evidence exchange follows a structured sequence: opponent files evidence → patentee files reply evidence within two months → opponent files evidence in reply within one month → evidence stage closes. Each round must respond to the other party’s submissions. Introducing new grounds or new prior art after the evidence stage closes is impermissible and will be excluded.
Step 6 — Attend the Opposition Board Process (Post-Grant) or Controller Hearing (Pre-Grant). In post-grant proceedings, the Opposition Board reviews all submissions and issues a written recommendation. Both parties then appear before the Controller for an oral hearing. In pre-grant proceedings, the Controller may conduct a preliminary hearing to determine whether the opposition is made out on prima facie grounds before proceeding to a full hearing. Prepare concise, claim-mapped submissions — clarity and specificity carry disproportionate weight in patent hearings.
Step 7 — Plan Your Appeal Strategy in Advance. If the Controller’s decision is adverse, the aggrieved party may appeal to the jurisdictional High Court of Commercial Jurisdiction within three months of the order. Given that the IPAB has been abolished and patent appeals now proceed before High Courts, briefing appellate counsel before the Controller’s decision — rather than after — is a significant strategic advantage.
Parallel Proceedings Note: In Vringo Infrastructure Inc. v. ZTE Corporation (Delhi HC, 2015), the Court granted an interim injunction while simultaneously acknowledging that validity challenges under Section 64 would proceed alongside the main infringement suit. This confirms that where an infringement suit is filed, the defendant can raise patent invalidity as a counter-claim under Section 64 — which covers the same grounds as Section 25(2) but without the 12-month time limit. Section 64 and Section 25(2) are complementary remedies, not alternatives.
Key Takeaway: Patent opposition is won or lost in the preparation phase — prior art research, ground selection, expert identification, and evidence assembly — not at the hearing stage. Invest your resources before filing, not after. [INTERNAL LINK: IP Enforcement and Litigation — Unimarks Legal Solutions]
Common Mistakes That Cause Patent Oppositions to Fail
Insufficient claim mapping. Citing a prior art document without explaining precisely how it anticipates each claim element is the most frequent cause of opposition failure. The opponent must conduct a claim-by-claim analysis demonstrating that the prior art discloses every element of the challenged claim. A generalised argument that “the concept was known” carries no legal weight before the Controller.
Missing the post-grant deadline. The 12-month post-grant window under Section 25(2) is absolute. Missing it forecloses the most cost-effective challenge route entirely. Calendar the grant publication date the moment you identify a target patent.
Relying on inadmissible evidence. Unnotarised affidavits, unauthenticated documents, and expert opinions from witnesses who cannot be cross-examined are routinely excluded by the Controller. Procedural rigour in evidence preparation is as important as substantive legal arguments.
Ignoring Section 8 compliance as a standalone ground. Many opponents focus exclusively on technical invalidity grounds and overlook the documentary Section 8 ground entirely. Where the applicant has received and failed to disclose adverse foreign examination reports, this can be established from the prosecution file history alone — without any technical expert evidence.
Filing too many weak grounds. Pleading every available ground without evidentiary support signals a scattergun approach. Experienced Controllers give less weight to oppositions that combine well-evidenced primary grounds with five or six unsubstantiated secondary grounds. Selectivity and focus are more persuasive than comprehensiveness.
Key Takeaway: Most patent oppositions fail not because the underlying merits are weak but because the evidence preparation is inadequate. A focused, well-evidenced opposition on two or three strong grounds consistently outperforms a broad challenge on seven grounds with thin support.
Practical Roadmap: Twelve Steps to a Successful Patent Opposition
- Establish a patent journal monitoring system for your relevant IPC codes and competitor entities at ipindia.gov.in.
- On identifying a target application or granted patent, immediately calculate your pre-grant or post-grant deadline.
- Commission a six-database prior art search — IP India, PATENTSCOPE, Espacenet, USPTO, Google Patents, technical literature.
- Map your prior art to specific claim elements — identify which grounds are evidentially sustainable.
- Audit the foreign prosecution history for Section 8 compliance deficiencies.
- Identify and instruct a technical expert capable of providing an affidavit and withstanding cross-examination.
- Prepare a notarised expert affidavit with a detailed claim-by-claim technical analysis.
- File Form 7 (pre-grant, ₹1,500–₹6,000) or Form 7A (post-grant, ₹3,000–₹12,000) with the complete evidence bundle through the IP India e-filing portal.
- Docket all evidence exchange deadlines — patentee’s two-month reply window and your one-month reply window in post-grant proceedings.
- Prepare for the Controller hearing with claim-mapped, concise oral submissions.
- Brief appellate counsel at the High Court before the Controller’s decision issues.
- Explore parallel settlement or licensing discussions — a narrowing of claims through opposition may be commercially equivalent to outright revocation.
Conclusion: Patent Opposition as a Strategic Business Tool
Patent opposition in India is one of the most powerful mechanisms available to businesses operating in innovation-driven sectors. The dual-track system — pre-grant under Section 25(1) and post-grant under Section 25(2) — gives third parties meaningful access to challenge patents that would otherwise create unjustified monopolies over non-novel, obvious, or otherwise unpatentable subject matter.
As Novartis AG v. Union of India demonstrated, a strategically well-executed opposition can have consequences extending far beyond any single patent dispute — shaping regulatory interpretation, influencing industry pricing, and establishing precedents that govern an entire sector’s patent landscape for years. The mechanism is available to any challenger willing to invest in the preparation it requires.
At Unimarks Legal Solutions, our patent advisory team assists businesses in identifying challengeable patents, conducting prior art searches, preparing opposition filings, engaging technical experts, and representing clients before the Controller and in High Court appeals. If a patent in your sector is restricting your commercial freedom — or if you need to defend your patent against a Section 25 challenge — contact our team for a confidential consultation.
Consult our Patent Advisory Team → Patent Registration and IP Advisory — Unimarks Legal Solutions
About the Author
Advocate Suresh Kumar has a law practice specialising in Intellectual Property Rights, Commercial legal advisory, debt recovery, commercial litigation, and dispute resolution for domestic and international clients. He is enrolled with the Bar Council of Tamil Nadu and Puducherry and represents clients before all courts and forums in Chennai, Tamil Nadu. This article reflects his understanding of the current legal position and is intended solely for informational purposes.
Disclaimer
This article is published by Unimarks Legal for informational purposes only. It is not intended to constitute legal advice or to create an attorney-client relationship. The contents are based on Indian law as applicable at the time of writing and are subject to change. Readers should not act upon the information in this article without seeking independent legal counsel. Every legal situation is unique, and the application of law depends on specific facts and circumstances. Past results do not guarantee future outcomes. This publication is made in compliance with the Bar Council of India Rules, which prohibit advertising or solicitation by advocates. Any information received through this article should not be construed as legal advice.
For specific legal guidance on your matter, you may consult a qualified advocate in your jurisdiction.
